Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share, representing a payout of 18% on the face value of Rs 10 per share, for the financial year ended March 31, 2026.
Dividend Proposal Details
The board of directors has proposed a final dividend of Rs 1.80 per equity share for FY26. This dividend, if approved by shareholders at the company's ensuing Annual General Meeting, will be paid out on shares with a face value of Rs 10 each. The 18% dividend payout reflects the company's commitment to returning value to its shareholders.
For investors holding shares of Lincoln Pharmaceuticals on the record date, the dividend will be credited post-approval at the AGM. Shareholders are advised to track official announcements from the company regarding the AGM schedule and record date for dividend eligibility.
What the Dividend Means for Shareholders
A final dividend proposed after the end of a fiscal year is a common practice among listed companies in India. The recommendation comes as Lincoln Pharmaceuticals seeks shareholder approval in the upcoming AGM, which is standard procedure for such corporate actions.
For a shareholder holding 100 shares of Lincoln Pharmaceuticals, the proposed dividend would translate to a payout of Rs 180 before applicable taxes. The actual amount received may vary based on the securities transaction tax and other statutory deductions as per prevailing tax laws.
- Proposed dividend: Rs 1.80 per share
- Dividend percentage: 18% of face value
- Face value per share: Rs 10
- Approval required: Shareholders at AGM
- Relevant financial year: FY26 (ended March 31, 2026)
Corporate Governance and Shareholder Rights
As a listed entity on the Bombay Stock Exchange, Lincoln Pharmaceuticals follows regulatory guidelines for disclosure of corporate actions. The dividend recommendation is subject to shareholder approval, ensuring transparency in the company's capital allocation decisions.
Investors holding Lincoln Pharmaceuticals (BSE) shares should monitor official communications from the company regarding the AGM date, agenda items, and the record date fixed for determining dividend entitlement. Participation in the AGM allows shareholders to vote on the proposed dividend and other matters on the agenda.
Track Further Updates
Lincoln Pharmaceuticals has disclosed this corporate action through the BSE filing platform. The company will issue further notifications regarding the AGM schedule and dividend payment timeline following shareholder approval. Investors are encouraged to review the official BSE announcements and the company's investor relations communications for complete details.
This article is for informational purposes only and does not constitute financial or investment advice. Investors should conduct their own research or consult a SEBI-registered investment advisor before making any investment decisions.